ExodusPoint Capital Management, LP

Position in PRTA — Prothena Corp Public Ltd Co

CIK 1736225 NEW YORK, NY

Position in PRTA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$803,005

+$694,414 QoQ

Shares Held

82,023

+634.2% QoQ

Ownership

0.160%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#51

of 187 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. PRTA ranks #62 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$803,005	82,023	+634.2%	Shares	Sole	2026-08-14
2026-03-31	$108,591	11,172	-87.3%	Shares	Sole	2026-05-14
2025-12-31	$840,304	87,990	+190.8%	Shares	Sole	2026-02-17
2025-09-30	$295,279	30,254	-48.7%	Shares	Sole	2025-11-14
2025-06-30	$357,632	58,918	+42.8%	Shares	Sole	2025-08-13
2025-03-31	$510,741	41,272	-12.4%	Shares	Sole	2025-05-14
2024-06-30	$972,288	47,107	-22.6%	Shares	Sole	2024-08-13
2023-09-30	$2,936,157	60,853	+44.2%	Shares	Sole	2023-11-13
2022-06-30	$1,146,082	42,213	-40.3%	Shares	Sole	2022-08-22
2022-03-31	$2,585,572	70,702	-56.6%	Shares	Sole	2022-05-13
2021-12-31	$8,045,185	162,858	+937.8%	Shares	Sole	2022-02-11
2020-12-31	$188,460	15,692	-33.2%	Shares	Sole	2021-02-16
2020-09-30	$234,765	23,500	+88.2%	Shares	Sole	2020-11-16
2020-06-30	$130,624	12,488	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.